“These Tablets Can Cause Blood Clots and Heart Attacks” — Important Context
This headline is too vague to be safe or medically useful. Some medicines really do carryitinib, baricitinib, and upadacitinib, because of increased risks of serious cardiovascular events such as heart attack or stroke and blood clots in warnings about increased risks of blood clots or serious cardiovascular events, but the risk depends on the specific drug, dose, medical condition, age, and other risk factors.
For example, the FDA has required prominent warnings for certain JAK inhibitors, including tofacitinib, baricitinib, and upadacitinib, because of increased risks of serious cardiovascular events such as heart attack or stroke and blood clots in particular patient populations. U.S. Food and Drug Administration+1
Other medications have very different risks. For example, blood-thinning medicines generally reduce clotting, but can increase the risk of serious bleeding. U.S. Food and Drug Administration+1
Don’t stop a prescribed tablet because of a headline
Stopping some medicines suddenly can itself be dangerous. The correct response to a suspected medication side effect is to check the medication’s name and speak with a doctor or pharmacist rather than discontinuing it independently.
If you send me the names or a photo of the tablets mentioned in the post, I can explain which ones actually have documented blood-clot or heart-attack warnings and what the evidence says.
